Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
Diabetic kidney disease (DKD) is a complex and multifactorial disorder associated with deregulations in a large number of different biological pathways on the molecular level. Using the 2 established biomarkers, estimated glomerular filtration rate (eGFR) and albuminuria will not allow allocating pa...
Main Authors: | Paul Perco, Michelle Pena, Hiddo J.L. Heerspink, Gert Mayer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024918303437 |
Similar Items
-
MULTIMARKER DIAGNOSTIC PANELS FOR ATHEROSCLEROSIS
by: V. A. Metelskaya
Published: (2018-09-01) -
Progress and opportunities in measuring the burden of Chronic Kidney Disease
by: Priya Vart, et al.
Published: (2022-09-01) -
A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
by: Michelle J Pena, et al.
Published: (2015-01-01) -
The geographical distribution of leadership in globalized clinical trials.
by: Jarno Hoekman, et al.
Published: (2012-01-01) -
Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer
by: Edgell Tracey A, et al.
Published: (2010-06-01)